Analgesic Use and the Risk of Primary Adult Brain Tumor

Overview

Journal Eur J Epidemiol

Specialty Public Health

Date 2016 Feb 20

PMID 26894804

Citations 7

Authors

Kathleen M Egan

Louis B Nabors

Zachary J Thompson

Carrie M Rozmeski

Gabriella A Anic

Jeffrey J Olson

Renato V LaRocca

Sajeel A Chowdhary

Peter A Forsyth

Reid C Thompson

Affiliations

Soon will be listed here.

Abstract

Glioma and meningioma are uncommon tumors of the brain with few known risk factors. Regular use of aspirin has been linked to a lower risk of gastrointestinal and other cancers, though evidence for an association with brain tumors is mixed. We examined the association of aspirin and other analgesics with the risk of glioma and meningioma in a large US case-control study. Cases were persons recently diagnosed with glioma or meningioma and treated at medical centers in the southeastern US. Controls were persons sampled from the same communities as the cases combined with friends and other associates of the cases. Information on past use of analgesics (aspirin, other anti-inflammatory agents, and acetaminophen) was collected in structured interviews. Logistic regression was used to estimate odds ratios (ORs) and 95 % confidence intervals (CIs) for analgesic use adjusted for potential confounders. All associations were considered according to indication for use. A total of 1123 glioma cases, 310 meningioma cases and 1296 controls were included in the analysis. For indications other than headache, glioma cases were less likely than controls to report regular use of aspirin (OR 0.69; CI 0.56, 0.87), in a dose-dependent manner (P trend < 0.001). No significant associations were observed with other analgesics for glioma, or any class of pain reliever for meningioma. Results suggest that regular aspirin use may reduce incidence of glioma.

Citing Articles

Can Gentisic Acid Serve as a High-Performance Antioxidant with Lower Toxicity for a Promising New Topical Application?.

Cunha L, Lepore E, Medeiros C, Sorrechia R, Pietro R, Correa M Life (Basel). 2024; 14(8).

PMID: 39202764 PMC: 11355177. DOI: 10.3390/life14081022.

Impact of anesthesia and analgesia techniques on glioblastoma progression. A narrative review.

Privorotskiy A, Bhavsar S, Lang F, Hu J, Cata J Neurooncol Adv. 2020; 2(1):vdaa123.

PMID: 33205044 PMC: 7653686. DOI: 10.1093/noajnl/vdaa123.

Identification of Pre-Diagnostic Metabolic Patterns for Glioma Using Subset Analysis of Matched Repeated Time Points.

Jonsson P, Antti H, Spath F, Melin B, Bjorkblom B Cancers (Basel). 2020; 12(11).

PMID: 33198241 PMC: 7696703. DOI: 10.3390/cancers12113349.

Aspirin, NSAIDs, and Glioma Risk: Original Data from the Glioma International Case-Control Study and a Meta-analysis.

Amirian E, Ostrom Q, Armstrong G, Lai R, Gu X, Jacobs D Cancer Epidemiol Biomarkers Prev. 2018; 28(3):555-562.

PMID: 30482874 PMC: 6401283. DOI: 10.1158/1055-9965.EPI-18-0702.

Associations between aspirin use and the risk of cancers: a meta-analysis of observational studies.

Qiao Y, Yang T, Gan Y, Li W, Wang C, Gong Y BMC Cancer. 2018; 18(1):288.

PMID: 29534696 PMC: 5851082. DOI: 10.1186/s12885-018-4156-5.

References

Loh J, Hwang S, Lieu A, Huang T, Howng S . The alteration of prostaglandin E2 levels in patients with brain tumors before and after tumor removal. J Neurooncol. 2002; 57(2):147-50. DOI: 10.1023/a:1015782809966. View

culic V . Aspirin for preventing venous thromboembolism. N Engl J Med. 2013; 368(8):772. DOI: 10.1056/NEJMc1215492. View

Greenhough A, Smartt H, Moore A, Roberts H, Williams A, Paraskeva C . The COX-2/PGE2 pathway: key roles in the hallmarks of cancer and adaptation to the tumour microenvironment. Carcinogenesis. 2009; 30(3):377-86. DOI: 10.1093/carcin/bgp014. View

Rolle C, Sengupta S, Lesniak M . Mechanisms of immune evasion by gliomas. Adv Exp Med Biol. 2012; 746:53-76. DOI: 10.1007/978-1-4614-3146-6_5. View

Thun M, Jacobs E, Patrono C . The role of aspirin in cancer prevention. Nat Rev Clin Oncol. 2012; 9(5):259-67. DOI: 10.1038/nrclinonc.2011.199. View

Daugherty S, Moore S, Pfeiffer R, Inskip P, Park Y, Hollenbeck A . Nonsteroidal anti-inflammatory drugs and glioma in the NIH-AARP Diet and Health Study cohort. Cancer Prev Res (Phila). 2011; 4(12):2027-34. PMC: 3388115. DOI: 10.1158/1940-6207.CAPR-11-0274. View

McIlhatton M, Tyler J, Burkholder S, Ruschoff J, Rigas B, Kopelovich L . Nitric oxide-donating aspirin derivatives suppress microsatellite instability in mismatch repair-deficient and hereditary nonpolyposis colorectal cancer cells. Cancer Res. 2007; 67(22):10966-75. DOI: 10.1158/0008-5472.CAN-07-2562. View

Braganza M, Kitahara C, Berrington de Gonzalez A, Inskip P, Johnson K, Rajaraman P . Ionizing radiation and the risk of brain and central nervous system tumors: a systematic review. Neuro Oncol. 2012; 14(11):1316-24. PMC: 3480263. DOI: 10.1093/neuonc/nos208. View

Ferris J, McCoy L, Neugut A, Wrensch M, Lai R . HMG CoA reductase inhibitors, NSAIDs and risk of glioma. Int J Cancer. 2012; 131(6):E1031-7. PMC: 3394887. DOI: 10.1002/ijc.27536. View

10.

Xu K, Shu H . EGFR activation results in enhanced cyclooxygenase-2 expression through p38 mitogen-activated protein kinase-dependent activation of the Sp1/Sp3 transcription factors in human gliomas. Cancer Res. 2007; 67(13):6121-9. DOI: 10.1158/0008-5472.CAN-07-0141. View

11.

Gasic G, Gasic T, Stewart C . Antimetastatic effects associated with platelet reduction. Proc Natl Acad Sci U S A. 1968; 61(1):46-52. PMC: 285903. DOI: 10.1073/pnas.61.1.46. View

12.

Perdiki M, Korkolopoulou P, Thymara I, Agrogiannis G, Piperi C, Boviatsis E . Cyclooxygenase-2 expression in astrocytomas. Relationship with microvascular parameters, angiogenic factors expression and survival. Mol Cell Biochem. 2006; 295(1-2):75-83. DOI: 10.1007/s11010-006-9275-7. View

13.

Schwartzbaum J, Jonsson F, Ahlbom A, Preston-Martin S, Malmer B, Lonn S . Prior hospitalization for epilepsy, diabetes, and stroke and subsequent glioma and meningioma risk. Cancer Epidemiol Biomarkers Prev. 2005; 14(3):643-50. DOI: 10.1158/1055-9965.EPI-04-0119. View

14.

Fang Z, Kulldorff M, Gregorio D . Brain cancer mortality in the United States, 1986 to 1995: a geographic analysis. Neuro Oncol. 2004; 6(3):179-87. PMC: 1872002. DOI: 10.1215/S1152851703000450. View

15.

Hung W . Anti-metastatic action of non-steroidal anti-inflammatory drugs. Kaohsiung J Med Sci. 2008; 24(8):392-7. DOI: 10.1016/S1607-551X(08)70162-1. View

16.

Shete S, Hosking F, Robertson L, Dobbins S, Sanson M, Malmer B . Genome-wide association study identifies five susceptibility loci for glioma. Nat Genet. 2009; 41(8):899-904. PMC: 4501476. DOI: 10.1038/ng.407. View

17.

Rothwell P, Fowkes F, Belch J, Ogawa H, Warlow C, Meade T . Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trials. Lancet. 2010; 377(9759):31-41. DOI: 10.1016/S0140-6736(10)62110-1. View

18.

Sareddy G, Geeviman K, Ramulu C, Prakash Babu P . The nonsteroidal anti-inflammatory drug celecoxib suppresses the growth and induces apoptosis of human glioblastoma cells via the NF-κB pathway. J Neurooncol. 2011; 106(1):99-109. DOI: 10.1007/s11060-011-0662-x. View

19.

Buccoliero A, Caldarella A, Arganini L, Mennonna P, Gallina P, Taddei A . Cyclooxygenase-2 in oligodendroglioma: possible prognostic significance. Neuropathology. 2004; 24(3):201-7. DOI: 10.1111/j.1440-1789.2004.00554.x. View

20.

Friis S, Sorensen H, McLaughlin J, Johnsen S, Blot W, Olsen J . A population-based cohort study of the risk of colorectal and other cancers among users of low-dose aspirin. Br J Cancer. 2003; 88(5):684-8. PMC: 2376336. DOI: 10.1038/sj.bjc.6600760. View